Vir Biotechnology Publishes New Research Characterizing Antibody Response to SARS-CoV-2 in the Journal CellGlobeNewsWire • 09/24/20
Vir Biotechnology to Present at H.C. Wainwright 22nd Annual Global Investment ConferenceGlobeNewsWire • 09/08/20
GlaxoSmithKline and partner Vir join the race to find a coronavirus antibody treatmentCNBC • 08/31/20
Vir Biotechnology and GSK Start Phase 2/3 Study of COVID-19 Antibody TreatmentGlobeNewsWire • 08/31/20
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial ResultsGlobeNewsWire • 08/11/20
Vir Biotechnology to Provide Corporate Update and Report Second Quarter 2020 Financial Results on August 11, 2020GlobeNewsWire • 07/28/20
Vir Biotechnology Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesGlobeNewsWire • 07/10/20
Vir Biotechnology Is Bucking The Biotech COVID-19 Trends, And Stands To WinThe Motley Fool • 06/01/20